Unum Group (UNM) Projected to Post Earnings on Tuesday

Unum Group (NYSE:UNM) is expected to issue its quarterly earnings data after the market closes on Tuesday, February 4th. Analysts expect the company to announce earnings of $2.14 per share and revenue of $3.29 billion for the quarter. Parties that wish to register for the company’s conference call can do so using this link.

Unum Group Stock Down 1.0 %

Shares of UNM stock opened at $76.25 on Monday. The company has a 50 day simple moving average of $74.23 and a two-hundred day simple moving average of $64.68. The stock has a market cap of $13.92 billion, a P/E ratio of 8.25, a P/E/G ratio of 1.09 and a beta of 0.81. Unum Group has a 12 month low of $46.39 and a 12 month high of $77.69. The company has a current ratio of 0.28, a quick ratio of 0.28 and a debt-to-equity ratio of 0.32.

Unum Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Friday, January 24th will be given a dividend of $0.42 per share. The ex-dividend date of this dividend is Friday, January 24th. This represents a $1.68 annualized dividend and a yield of 2.20%. Unum Group’s dividend payout ratio (DPR) is presently 18.18%.

Insider Transactions at Unum Group

In other Unum Group news, CAO Walter Lynn Rice, Jr. sold 1,500 shares of the business’s stock in a transaction on Thursday, November 7th. The shares were sold at an average price of $69.56, for a total transaction of $104,340.00. Following the transaction, the chief accounting officer now owns 8,361 shares in the company, valued at $581,591.16. The trade was a 15.21 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Christopher W. Pyne sold 3,250 shares of the stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $70.02, for a total value of $227,565.00. Following the completion of the sale, the executive vice president now owns 50,762 shares in the company, valued at approximately $3,554,355.24. The trade was a 6.02 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 102,914 shares of company stock valued at $7,677,945 in the last ninety days. Corporate insiders own 0.93% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on UNM. Truist Financial raised their price objective on Unum Group from $70.00 to $75.00 and gave the stock a “buy” rating in a research note on Friday, November 1st. Bank of America increased their price objective on shares of Unum Group from $54.00 to $63.00 and gave the stock a “neutral” rating in a research note on Thursday, October 10th. Wells Fargo & Company lifted their target price on shares of Unum Group from $74.00 to $81.00 and gave the company an “overweight” rating in a research note on Tuesday, January 14th. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $79.00 target price (up previously from $74.00) on shares of Unum Group in a research report on Tuesday, January 7th. Finally, BMO Capital Markets began coverage on Unum Group in a report on Thursday, January 23rd. They issued an “outperform” rating and a $91.00 price target on the stock. Four investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $79.00.

About Unum Group

Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.